Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Implementing methadone maintenance treatment in prisons in Malaysia.

Wickersham JA, Marcus R, Kamarulzaman A, Zahari MM, Altice FL.

Bull World Health Organ. 2013 Feb 1;91(2):124-9. doi: 10.2471/BLT.12.109132.

2.

Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.

Wickersham JA, Zahari MM, Azar MM, Kamarulzaman A, Altice FL.

Drug Alcohol Depend. 2013 Sep 1;132(1-2):378-82. doi: 10.1016/j.drugalcdep.2013.01.005. Epub 2013 Feb 13.

3.

Methadone maintenance treatment in Spain: the success of a harm reduction approach.

Torrens M, Fonseca F, Castillo C, Domingo-Salvany A.

Bull World Health Organ. 2013 Feb 1;91(2):136-41. doi: 10.2471/BLT.12.111054.

4.

Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.

Moradi G, Farnia M, Shokoohi M, Shahbazi M, Moazen B, Rahmani K.

Int J Health Policy Manag. 2015 Mar 12;4(9):583-9. doi: 10.15171/ijhpm.2015.60.

5.

Human resource development and capacity-building during China's rapid scale-up of methadone maintenance treatment services.

Li J, Wang C, McGoogan JM, Rou K, Bulterys M, Wu Z.

Bull World Health Organ. 2013 Feb 1;91(2):130-5. doi: 10.2471/BLT.12.108951.

6.

Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.

Farnia M, Ebrahimi B, Shams A, Zamani S.

Int J Drug Policy. 2010 Sep;21(5):422-4. doi: 10.1016/j.drugpo.2010.03.008. Epub 2010 Apr 21. Review.

PMID:
20413287
7.

Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan.

Huang YF, Kuo HS, Lew-Ting CY, Tian F, Yang CH, Tsai TI, Gange SJ, Nelson KE.

Addiction. 2011 Aug;106(8):1437-45. doi: 10.1111/j.1360-0443.2011.03443.x. Epub 2011 May 12.

PMID:
21438941
8.

Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.

Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, Noska A, Reddy M, Zaller N.

Lancet. 2015 Jul 25;386(9991):350-9. doi: 10.1016/S0140-6736(14)62338-2. Epub 2015 May 28.

9.

The trajectory of methadone maintenance treatment in Nepal.

Ambekar A, Rao R, Pun A, Kumar S, Kishore K.

Int J Drug Policy. 2013 Nov;24(6):e57-60. doi: 10.1016/j.drugpo.2013.06.001. Epub 2013 Jul 8.

PMID:
23845916
10.

HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.

Navadeh S, Mirzazadeh A, Gouya MM, Farnia M, Alasvand R, Haghdoost AA.

Sex Transm Infect. 2013 Nov;89 Suppl 3:iii33-6. doi: 10.1136/sextrans-2013-051295. Epub 2013 Aug 28.

11.

The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.

Altice FL, Azbel L, Stone J, Brooks-Pollock E, Smyrnov P, Dvoriak S, Taxman FS, El-Bassel N, Martin NK, Booth R, Stöver H, Dolan K, Vickerman P.

Lancet. 2016 Sep 17;388(10050):1228-48. doi: 10.1016/S0140-6736(16)30856-X. Epub 2016 Jul 14. Review.

12.

Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China.

Zhao Y, Shi CX, McGoogan JM, Rou K, Zhang F, Wu Z.

Bull World Health Organ. 2013 Feb 1;91(2):93-101. doi: 10.2471/BLT.12.108944.

13.

Preference of methadone maintenance patients for the integrative and decentralized service delivery models in Vietnam.

Tran BX, Nguyen LH, Phan HT, Nguyen LK, Latkin CA.

Harm Reduct J. 2015 Sep 17;12:29. doi: 10.1186/s12954-015-0063-0.

14.

Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam, Tanzania.

Ubuguyu O, Tran OC, Bruce RD, Masao F, Nyandindi C, Sabuni N, McCurdy S, Mbwambo J, Lambdin BH.

Int J Drug Policy. 2016 Apr;30:74-81. doi: 10.1016/j.drugpo.2016.03.005. Epub 2016 Mar 11.

15.

Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.

Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL.

Drug Alcohol Depend. 2011 Jul 1;116(1-3):151-7. doi: 10.1016/j.drugalcdep.2010.12.001. Epub 2011 Jan 12.

16.

Methadone maintenance therapy outcomes in Iran.

Noori R, Narenjiha H, Aghabakhshi H, Habibi G, Khoshkrood Mansoori B.

Subst Use Misuse. 2012 Jun;47(7):767-73. doi: 10.3109/10826084.2010.517726. Epub 2012 Mar 15.

PMID:
22416897
17.

Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.

Vijay A, Bazazi AR, Yee I, Kamarulzaman A, Altice FL.

J Subst Abuse Treat. 2015 Jul;54:29-36. doi: 10.1016/j.jsat.2015.01.014. Epub 2015 Feb 18.

18.

New treatment gives hope to East Africa's drug users.

[No authors listed]

Bull World Health Organ. 2013 Feb 1;91(2):89-90. doi: 10.2471/BLT.13.030213.

19.

Policy implementation of methadone maintenance treatment and HIV infection: evidence from Hubei province, China.

Dai J, Zhao L, Liang Y.

Subst Abuse Treat Prev Policy. 2013 Nov 5;8:38. doi: 10.1186/1747-597X-8-38.

20.

Improvement of quality of life following 6 months of methadone maintenance therapy in Malaysia.

Baharom N, Hassan MR, Ali N, Shah SA.

Subst Abuse Treat Prev Policy. 2012 Aug 1;7:32. doi: 10.1186/1747-597X-7-32.

Supplemental Content

Support Center